Revolutionary liquid biopsy technology to detect cell death in specific human tissues using circulating cell-free DNA. Each tissue has a unique DNA methylation pattern, which is retained in cell-free DNA released from dying cells to blood, and can be used to determine the sources of dying cells. Using the technology, Dor, circulating DNA expert; and Avni, Bone marrow transplant expert/physician, will develop a novel approach for the detection and monitoring of Graft Versus Host Disease(GVHD), an alloimmune disease affecting bone marrow transplant patients and the leading cause for morbidity with a high mortality rate...